![]() |
![]() |
J Acupunct Res > Volume 33(2); 2016 > Article |
|
First author (year) | sample size | (A) Interventions group | (B) Control group | Outcome assesment | Results | jadad scale |
---|---|---|---|---|---|---|
Fan15)* –2016 |
(A) n=25 (B) n=26 |
Fire needling • Once in 5 days × 4 times •Skin lesions |
Tazarotene cream (external use) +Clindamycin phosphate gel (external use) |
ER† |
(A): 96.0 % (B): 73.1 % (p<0.05) |
2 |
Jiang12)* –2014 |
(A) n=30 (B) n=30 |
Fire needling • Once in 5 days × 4 times •Skin lesions |
Doxycycline (oral medication) +Adapalene gel (external use) |
ER |
(A): 69.0 % (B): 40.0 % (p<0.05) |
3 |
Wang23)* –2014 |
(A) n=42 (B) n=38 |
Fire needling • Once in 2~3 days × 10 times •Skin lesions |
Acupuncture •Skin lesions, LI11, LI4, SP10, SP6 |
ER |
(A): 92.8 % (B): 78.9 % (p<0.05) |
1 |
Huang27) –2004 |
(A) n=71 (B) n=57 |
Fire needling • Once a week × 4 times •Skin lesions |
0.025 % Tretinoin cream | ER |
(A: 95.8 % (B): 73.7 % (p<0.01) |
1 |
First author (year) | sample size | (A) Interventions group | (B) Control group | Outcome assesment | Results | jadad scale |
---|---|---|---|---|---|---|
Yang24) -2015 |
(A) n=23 (B) n=23 |
Fire needling •Twice a week × 8 times •Skin lesions +Xiaocuotangjiajian |
Isotretinoin soft capsules (oral medication) | ER† |
(A): 87.0 % (B): 69.6 % (p<0.05) |
1 |
Zhang42)* -2015 |
(A) n=85 (B) n=85 |
Fire needling •Unrecorded for 4 weeks •Skin lesions +Zhongtongan Capsule |
Roxithromycin (oral medication) +Clindamycin phosphate gel (external use) |
ER |
(A): 78.8 % (B): 51.8 % (p<0.05) |
1 |
Wang18)* -2015 |
(A) n=31 (B) n=31 |
Fire needling •Unrecorded for 2 months •Skin lesions +Acupuncture (LI20, SI18, CV24, Ex-HN3, LI4, LI11, SP10, ST44, SP9, ST36) +Moving cup manipulation +Qingrechushitang |
Minocycline hydrochloride (oral medication)(br)+Clindamycin phosphate (external use) | ER |
(A): 90.32 % (B): 58.06 % (p<0.01) |
2 |
Wang14)* -2014 |
(A) n=75 (B) n=75 |
Fire needling •Twice a week×4 times •Skin lesions BL13,BL17, BL20, BL21, BL25 +Mahuangfuzixixintangjiajian |
Minocycline hydrochloride (oral medication) |
1) ER 2) IL-2‡ |
1) (A): 85.33 % (B): 53.33 % (p<0.05) 2) (A): 7.21 ± 4.22 (B): 10.19 ± 3.41 (p<0.05) |
2 |
Chen36)* -2014 |
(A) n=35 (B) n=35 |
Fire needling •Twice a week × 8 times •Skin lesions +Acupuncture +Plum-blossom needle and cupping therapy (GV14, BL13, BL15, BL17, BL21, BL23) |
Isotretinoin (oral medication) | ER |
(A): 85.71 (B): 65.71 (p<0.05) |
1 |
Mild group (A) n=35 (B) Control1: n=35 Control2: n=35 |
Control 1) Acupuncture •LI4, LI11, ST44, GB14, ST2 |
Mild group (A): 97.1 % (B) Control1: 88.6 %, Control2: 82.9 % (p<0.05) |
||||
Zheng26) -2010 |
Moderate group (A) n=40 (B) Control1: n=40 Control2: n=40 |
Fire needling •Once in 3~7 days for 8 times •Skin lesions +Blood-pricking therapy and cupping (BL13, BL15, BL18, BL20, BL23, BL25) |
Control 2) Metacycline (oral medication) +Hydrochloride clindamycin phosphate gel (external use) |
ER |
Moderate group (A): 95.0 % (B) Control1: 87.5 % Control2: 77.5 % (p<0.05) |
1 |
Severe group (A) n=35 (B) Control1: n=35 Control2: n=35 |
Severe group (A): 91.6 % (B) Control1: 85.7 %, Control2: 77.1 % (p<0.05) |
First author (year) | sample size | (A) Interventions group | (B) Control group | Outcome assesment | Results | jadad scale |
---|---|---|---|---|---|---|
Yang33)* -2015 |
(A) n=34 (B) n=33 |
Fire needling • Once or twice a week × 4 times •Skin lesions +Pingcuofangjiajian |
Xiaocuowan | ER† |
(A): 79.41 % (B): 42.42 % (p<0.05) |
1 |
Li16)* -2015 |
(A) n=32 (B) n=30 |
Fire needling •Twice a week × 20 times •Skin lesions +Cupping therapy •Skin lesions |
Acupuncture •GV14 Bl13 BL21 BL17 (selection of points according to syndrome) |
1) ER 2) Acne-QoL‡ |
1) (A): 71.88 % (B): 66.67 % (p<0.05) 2) •Self-perception: (A): 25.59 ± 5.30 (B): 22.69 ± 4.63 (p<0.01) • Role-emotional: (A): 26.24 ± 4.13 (B): 21.69 ± 7.13 (p<0.01) • Role-social: (A): 18.44 ± 2.13 (B): 17.32 ± 3.21 (p<0.05) |
2 |
Yang21) -2015 |
(A) n=45 (B) n=44 |
Fire needling • Once a week × 6 times •Skin lesions +Pipaqingfeiyinjiajian |
Pipaqingfeiyinjiajian | ER |
(A): 93.3 % (B): 70.5 % (p<0.05) |
0 |
Jiang28)* -2014 |
(A) n=84 (B) n=84 |
Fire needling •Once a week × 3 times •Skin lesions, BL13, BL15, BL18, BL20, BL23, CV6, CV4 +Herbal medicine after differentiation of syndrome |
Herbal medicine after differentiation of syndrome | ER |
(A): 97.6 % (B): 90.5 % (p<0.05) |
1 |
Deng20)* -2014 |
(A) n=30 (B) Control1: n=30 Control2: n=30 |
Fire needling •Once a week × 8 times •Skin lesions +Moxibustion on Aconiti Lateralis Preparata Radix cake (ST36, CV4, CV6) |
Control 1) Fire needling •Same as (A) Control 2) Moxibustion •Same as (A) |
ER |
(A: 90.00 % (B) Control 1: 73.33 %, Control 2: 70.00 % (p<0.05: (A) and Control 1) (p<0.05: (A) and Control 2) |
1 |
Yang34)* -2014 |
(A) n=60 (B) n=60 |
Fire needling • Twice a week × 4 times •Skin lesions +Xiaocuosanjietang |
Xiaocuosanjietang | ER |
(A: 80.0 % (B): 55.0 % (p<0.05) |
1 |
Li10)* -2011 |
(A) n=23 (B) n=22 |
Fire needling •Once a week × 8 times •Skin lesions, BL13, BL15, BL18, BL20, BL23, CV12, ST25, CV6, CV4 +Yahnhuotangjiajian |
Yahnhuotangjiajian | ER |
(A): 95.65 % (B): 72.73 % (p<0.05) |
2 |
Zheng26) -2010 |
Mild group (A) n=35 (B) Control1: n=35 Control2: n=35 |
Fire needling •Once in 3~7 days for 8 weeks •Skin lesions +Blood-pricking therapy and cupping (BL13, BL15, BL18, BL20, BL23, BL25) |
Control 1) Acupuncture •LI4, LI11, ST44, GB14, ST2 |
ER |
Mild group (A): 97.1 % (B) Control1: 88.6 %, Control2: 82.9 % (p<0.05) |
1 |
Moderate group (A) n=40 (B) Control1: n=40 Control2: n=40 |
Moderate group (A): 95.0 % (B) Control1: 87.5 %, Control2: 77.5 % (p<0.05) |
|||||
Severe group (A) n=35 (B) Control1: n=35 Control2: n=35 |
Control 2) Metacycline (oral medication) +Hydrochloride clindamycin phosphate gel (external use) |
Severe group (A): 91.6 % (B) Control1: 85.7 %, Control2: 77.1 % (p<0.05) |
First author (year) | sample size | (A) Interventions group | (B) Control group | Outcome assesment | Results | jadad scale |
---|---|---|---|---|---|---|
Hu35)* -2015 |
(A) n=30 (B) n=30 |
Fire needling • Every other week × 8 times •Skin lesions +Xiaocuotang |
Adapalene gel (external use) +Xiaocuotang |
ER† |
(A): 23.3 % (B): 10.0 % (p<0.05) |
1 |
Tao37)* -2014 |
(A) n=33 (B) n=30 |
Fire needling • Once in 5 days × 6 times •Skin lesions +Moving cup manipulation +blood-pricking therapy and cupping |
Yiqing capsule (oral medication) +Fusidic acid cream (external use) |
ER |
(A): 100.00 % (B): 83.33 % (p<0.05) |
1 |
Huang32)* -2012 |
(A) n=44 (B) n=44 |
Fire needling • Once a week × 4 times +Sanpixiaocuotangjiajian |
Clindamycin phosphate gel (external use) +Sanpixiaocuotangjiajian |
ER |
(A): 86.83 ± 5.61 (B): 53.48 ± 7.82 (p<0.05) |
1 |
First author (year) | sample size | (A) Interventions group | (B) Control group | Outcome assesment | Results | jadad scale |
---|---|---|---|---|---|---|
Jiang13)* -2015 |
(A) n=28 (B) n=29 |
Fire needling • Once a week × 4 times •Skin lesions +Isotretinoin soft capsules (oral medication) |
Isotretinoin soft capsules (oral medication) | ER† |
(A): 89.3 % (B): 34.5 % (p<0.01) |
3 |
•Self-perception: (A): 3.76 ± 1.88 (B): 2.37 ± 2.24 (p<0.01) |
||||||
Li30)* -2015 |
(A) n=32 (B) n=29 |
Fire needling • Once a week × 4 times •Skin lesions +Blue and red light therapy +Gypsum chinese medicine mask sheet |
Qingrexiaocuotang | Change of Acne-QoL before and after interventions |
• Role-emotional: (A): 6.27 ± 2.42 (B): 2.19 ± 1.94 (p<0.01) |
1 |
• Role-social: (A): 5.36 ± 2.12 (B): 3.03 ± 2.58 (p<0.01) |
||||||
Li38)* -2015 |
(A) n=58 (B) n=50 |
Fire needling •Twice a week × 4 times •Skin lesions +Huajianxiaocuoyinjiajian +Blue and red light therapy |
Huajianxiaocuoyinjiajian | ER |
(A): 96.6 % (B): 72.0 % (p<0.05) |
1 |
Wu29)* -2015 |
(A) n=48 (B) n=47 |
Fire needling • Once a week •Skin lesions +Chinese medicine mask sheet Blue and red light therapy |
Chinese medicine mask sheet +Blue and red light therapy |
1) ER 2) GAGS‡ |
1) (A): 95.83 % (B): 74.47 % (p<0.05) 2) (A): 4.56 ± 1.71 (B): 29.78 ± 7.72 (p<0.05) |
1 |
Liu11)* -2015 |
(A) n=30 (B) n=30 |
Fire needling • Once a week × 8 times •Skin lesions +Blue and red lights therapy |
Blue and red light therapy |
1) ER 2) GAGS |
1) (A): 83.3 % (B): 50 % (p<0.05) 2) (A): 2.33 ± 2.11 (B): 9.27 ± 2.03 (p<0.05) |
2 |
Chen17)* -2015 |
(A) n=57 (B) n=63 |
Fire needling • Once a week × 4 times •Skin lesions +Blue and red light therapy +Mori Cortex Radicis mask sheet +Hospital original herbal medicine Qingfu 2 (oral) |
Blue and red light therapy +Hospital original herbal medicine Qingfu 2 (oral) |
ER |
(A: 86.0 % (B): 46.0 % (p<0.05) |
2 |
Cui22)* -2014 |
(A) n=20 (B) n=20 |
Fire needling •Twice a week × 5 times •Skin lesions +Qingrejieduyin +Clindamycin phosphate gel (external use) |
Tanshinone capsule +Clindamycin phosphate gel (external use) |
ER |
(A): 90 % (B): 50 % (p<0.01) |
1 |
Fu40)* -2014 |
(A) n=30 (B) n=30 |
Fire needling • Once a week × 8 times •Skin lesions +20 % fruit acid |
20 % fruit acid | ER |
(A): 83.3 % (B): 63.3 % (p<0.05) |
1 |
Tian41)* -2014 |
(A) n=220 (B) n=212 |
Fire needling •Twice a week × 8 times •Skin lesions +Helium-Neon lasers |
Helium-Neon lasers | ER |
(A): 82.7 % (B): 77.4 % (p<0.05) |
0 |
Shen25) -2013 |
(A) n=100 (B) n=100 |
Fire needling •Twice a week × 8 times •Skin lesions +Amikacin sulfate solution (external use) +Pingcuotang |
Pingcuotang | ER |
(A): 97.0 % (B): 80.0 % (p<0.01) |
1 |
Guo39)* -2011 |
(A) n=65 (B) n=60 |
Fire needling • Twice a week × 2 times •Skin lesions +Clarithromycin (oral medication) +Clindamycin and Chlorphenamine Maleate topical solution (external use) |
Clarithromycin (oral medication) +Clindamycin and Chlorphenamine Maleate topical solution (external use) |
ER |
(A): 95.38 % (B): 78.33 % (p<0.01) |
1 |
![]() |
![]() |